tci Medicare Compliance & Reimbursement - 2020 Issue Q2
Quality Payment Program: Get MIPS Credit for COVID-19 Clinical Trial Data
Subscribe or sign in to view the full article.
Article Overview
This article covers a 2020 CMS update to the Quality Payment Program and Merit-Based Incentive Payment System (MIPS) that created a new improvement activity option tied to COVID-19 clinical trial participation. It is relevant to clinicians and coding/billing professionals tracking MIPS reporting requirements, category weights, and pandemic-related reporting relief. The article also references broader MIPS scoring context, agency guidance, and the types of clinical data reporting platforms involved.
Why This Topic Matters
The update may affect how eligible clinicians document participation in qualifying COVID-19 research for MIPS reporting. It also helps readers understand the related 2020 performance year scoring framework and the agency resources supporting submission.
Article Sections
-
Background and CMS update
Introduces the Quality Payment Program context and the CMS announcement affecting MIPS reporting for clinicians involved in COVID-19 research.
-
How this option impacts overall scoring
Summarizes the broader MIPS performance categories, category weights, and threshold framework for the relevant reporting year.
-
COVID-19 Clinical Trials improvement activity
Describes the new improvement activity option and the general type of participation it is intended to recognize within MIPS reporting.
-
IT input and data submission tools
Discusses CMS encouragement around using open source tools and clinical data repositories or registries for submission-related workflow.
-
CMS statement and resources
Notes the agency’s public statement and points readers to referenced CMS and clinical trials resources.
What You Will Learn
- How CMS connected COVID-19 clinical trial participation to MIPS improvement activity reporting
- What the article says about the 2020 MIPS performance categories and scoring context
- Which types of clinicians and research activities are discussed in the update
- What general submission and resource options are mentioned for reporting clinical trial data
Who Should Read This
- MIPS-eligible clinicians
- Physicians and nonphysician practitioners
- Practice administrators
- Medical billing and coding professionals
- Quality reporting staff
Codes Discussed
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com